These results indicated that the YSHS granule not only reduced the deposition of extracellular matrix, but also promoted the degradation of extracellular matrix by up-regulating the expression of MMP9, thus alleviating glomerular fibrosis induced by ADR, and effectively delaying the progress of chronic kidney diseases. The gene discussed is MMP9; the disease is chronic kidney disease.